239 related articles for article (PubMed ID: 18039111)
1. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.
Skovronsky DM; Lee VM; Trojanowski JQ
Annu Rev Pathol; 2006; 1():151-70. PubMed ID: 18039111
[TBL] [Abstract][Full Text] [Related]
2. Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases.
Maiti P; Dunbar GL
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857538
[TBL] [Abstract][Full Text] [Related]
3. Amyloid diseases: abnormal protein aggregation in neurodegeneration.
Koo EH; Lansbury PT; Kelly JW
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):9989-90. PubMed ID: 10468546
[No Abstract] [Full Text] [Related]
4. Natural biomolecules and protein aggregation: emerging strategies against amyloidogenesis.
Sgarbossa A
Int J Mol Sci; 2012 Dec; 13(12):17121-37. PubMed ID: 23242152
[TBL] [Abstract][Full Text] [Related]
5. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy.
Fändrich M; Nyström S; Nilsson KPR; Böckmann A; LeVine H; Hammarström P
J Intern Med; 2018 Mar; 283(3):218-237. PubMed ID: 29360284
[TBL] [Abstract][Full Text] [Related]
6. Glia in the pathogenesis of neurodegenerative diseases.
Verkhratsky A; Parpura V; Pekna M; Pekny M; Sofroniew M
Biochem Soc Trans; 2014 Oct; 42(5):1291-301. PubMed ID: 25233406
[TBL] [Abstract][Full Text] [Related]
7. Ageing and neurodegenerative diseases.
Hung CW; Chen YC; Hsieh WL; Chiou SH; Kao CL
Ageing Res Rev; 2010 Nov; 9 Suppl 1():S36-46. PubMed ID: 20732460
[TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
Modi G; Pillay V; Choonara YE
Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative diseases.
Checkoway H; Lundin JI; Kelada SN
IARC Sci Publ; 2011; (163):407-19. PubMed ID: 22997874
[TBL] [Abstract][Full Text] [Related]
10. A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy.
Kim HY; Chia WK; Hsieh CJ; Saturnino Guarino D; Graham TJA; Lengyel-Zhand Z; Schneider M; Tomita C; Lougee MG; Kim HJ; Pagar VV; Lee H; Hou C; Garcia BA; Petersson EJ; O'Shea J; Kotzbauer PT; Mathis CA; Lee VM; Luk KC; Mach RH
J Med Chem; 2023 Sep; 66(17):12185-12202. PubMed ID: 37651366
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico Approaches.
Anwar S; Rehman W; Hussain R; Khan S; Alanazi MM; Alsaif NA; Khan Y; Iqbal S; Naz A; Hashmi MA
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513821
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.
Wang Z; Gonzalez KM; Cordova LE; Lu J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1907. PubMed ID: 37248794
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials.
Ghasemi M; Roshandel E; Mohammadian M; Farhadihosseinabadi B; Akbarzadehlaleh P; Shamsasenjan K
Stem Cell Res Ther; 2023 May; 14(1):122. PubMed ID: 37143147
[TBL] [Abstract][Full Text] [Related]
14. Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study.
Zhang Q; Li Q; Zhao H; Shu M; Luo M; Li Y; Ding Y; Shi S; Cheng X; Niu Q
Front Neurol; 2023; 14():1158366. PubMed ID: 37034095
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles from Mesenchymal Stem Cells: Towards Novel Therapeutic Strategies for Neurodegenerative Diseases.
Turano E; Scambi I; Virla F; Bonetti B; Mariotti R
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769247
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects.
Alkahtani S; Al-Johani NS; Alarifi S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674852
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and
Sağlık BN; Levent S; Osmaniye D; Evren AE; Karaduman AB; Özkay Y; Kaplancıklı ZA
ACS Omega; 2022 Dec; 7(50):47378-47404. PubMed ID: 36570177
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Optimization of Culture Conditions for
Hien HTM; Thom LT; Ha NC; Tam LT; Thu NTH; Nguyen TV; Loan VT; Dan NT; Hong DD
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547927
[No Abstract] [Full Text] [Related]
19. Pyrogallol, Corilagin and Chebulagic acid target the "fuzzy coat" of alpha-synuclein to inhibit the fibrillization of the protein.
Bopardikar M; Koti Ainavarapu SR; Hosur RV
RSC Adv; 2022 Dec; 12(55):35770-35777. PubMed ID: 36545068
[TBL] [Abstract][Full Text] [Related]
20. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis.
Borràs C; Mercer A; Sirisi S; Alcolea D; Escolà-Gil JC; Blanco-Vaca F; Tondo M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
